Recent Advances in Lipid Nano-Carrier Systems for the Management of Inflammatory Diseases: A Comprehensive Review

Home > 2023, Vol. 11 No. 02 > Recent Advances in Lipid Nano-Carrier Systems for the Management of Inflammatory Diseases: A Comprehensive Review

Published: November 10, 2023

Download PDF

Download XML | Download HTML

Authors

Kumar Anand , Sayak Khawas , Apurva Singh , Rashmi Kumari and Neelima Sharma

DOI Number
https://doi.org/10.15415/jprtm.2023.112001

Keywords
Chronic obstructive pulmonary disease, Encapsulation efficiency, Inflammatory bowel disease, Lipid nanocarriers, Psoriasis, Pharmacokinetics

Abstract

Background: In the past two decades, extensive research has focused on lipid nanocarriers for targeted drug delivery to treat various diseases. Among these, inflammatory conditions pose a formidable challenge in modern healthcare, encompassing a diverse spectrum from autoimmune disorders to chronic inflammation. Effective therapeutic interventions necessitate the development of targeted and efficient delivery systems to address the complexities associated with drug administration.

Purpose: This review highlights different approaches of lipid-based nanocarriers to target various inflammatory diseases, such as rheumatoid arthritis, inflammatory bowel disease (IBD), psoriasis, asthma, and chronic obstructive pulmonary disease (COPD). It focuses on the advancements made in Lipid Nano-Carriers (LNC) with a special emphasis on their inherent safety, lower stability costs, and enhanced encapsulation efficiency.

Methods: Recent literature has been surveyed from PUBMED, GOOGLE SCHOLAR, etc., like search engines, for summarising detailed ongoing developments in the field of lipid nanocarriers
for inflammatory diseases, which could prove to be a novel carrier for efficient drug delivery with special emphasis on surface modifications, formulations, pharmacokinetics, and efficacy.

Conclusion: This review emphasizes recent researches in the field of lipid-based nano formulations for managing inflammatory disease, as well as extensive discussion on their limitations and future prospective.

References

Abdelkader, H., Alani, A. W., & Alany, R. G. (2014). Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations. Drug delivery, 21(2), 87–100. https://doi.org/10.3109/10717544.2013.838077
Agrawal, Y. O., Mahajan, U. B., Mahajan, H. S., & Ojha, S. (2020). Methotrexate-Loaded Nanostructured Lipid Carrier Gel Alleviates Imiquimod-Induced Psoriasis by Moderating Inflammation: Formulation, Optimization, Characterization, In-Vitro and In-Vivo Studies. International journal of nanomedicine, 15, 4763–4778. https://doi.org/10.2147/IJN.S247007
Agrawal, Y., Petkar, K. C., & Sawant, K. K. (2010). Development, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis. International journal of pharmaceutics, 401(1-2), 93–102. https://doi.org/10.1016/j.ijpharm.2010.09.007
Aib, S., Iqbal, K., Khan, N., Khalid, S., Adnan, M., Umair, S. M., & Dar, M. J. (2022). pH-sensitive liposomes for colonic co-delivery of mesalazine and curcumin for the treatment of ulcerative colitis. Journal of Drug Delivery Science and Technology, 72, 103335. https://doi.org/10.1016/j.jddst.2022.103335
Akombaetwa, N., Ilangala, A. B., Thom, L., Memvanga, P. B., Witika, B. A., & Buya, A. B. (2023). Current Advances in Lipid Nanosystems Intended for Topical and Transdermal Drug Delivery Applications. Pharmaceutics, 15(2), 656. https://doi.org/10.3390/pharmaceutics15020656
Algahtani, M. S., Ahmad, M. Z., & Ahmad, J. (2020). Nanoemulsion loaded polymeric hydrogel for topical delivery of curcumin in psoriasis. Journal of Drug Delivery Science and Technology, 59, 101847. https://doi.org/10.1016/j.jddst.2020.101847
Alipour, G., Dashti, S., & Hosseinzadeh, H. (2014). Review of pharmacological effects of Myrtuscommunis L. and its active constituents. Phytotherapy research: PTR, 28(8), 1125–1136. https://doi.org/10.1002/ptr.5122
Armstrong, A. W., & Read, C. (2020). Pathophysiology, clinical presentation, and treatment of psoriasis: a review. Jama, 323(19), 1945-1960. https://doi.org/10.1001/jama.2020.4006
Bayón-Cordero, L., Alkorta, I., & Arana, L. (2019).Application of Solid Lipid Nanoparticles to Improve the Efficiency of Anticancer Drugs. Nanomaterials (Basel, Switzerland), 9(3), 474. https://doi.org/10.3390/nano9030474
Beloqui, A., Memvanga, P. B., Coco, R., Reimondez-Troitiño, S., Alhouayek, M., Muccioli, G. G., Alonso, M. J., Csaba, N., de la Fuente, M., & Préat, V. (2016). A comparative study of curcumin-loaded lipid-based nanocarriers in the treatment of inflammatory bowel disease. Colloids and surfaces. B, Biointerfaces, 143, 327–335. https://doi.org/10.1016/j.colsurfb.2016.03.038
Bhardwaj, P., Tripathi, P., Pandey, S., Gupta, R., & Patil, P. R. (2022). Cyclosporine and pentoxifylline laden tailored niosomes for the effective management of psoriasis: in-vitro optimization, ex-vivo and animal study. International Journal of Pharmaceutics, 626, 122143. https://doi.org/10.1016/j.ijpharm.2022.122143
Bruner, L. P., White, A. M., & Proksell, S. (2023). Inflammatory Bowel Disease. Primary care, 50(3), 411–427. https://doi.org/10.1016/j.pop.2023.03.009
Campanati, A., Marani, A., Martina, E., Diotallevi, F., Radi, G., & Offidani, A. (2021). Psoriasis as an Immune-Mediated and Inflammatory Systemic Disease: From Pathophysiology to Novel Therapeutic Approaches. Biomedicines, 9(11), 1511. https://doi.org/10.3390/biomedicines9111511
Capon, F., Burden, A. D., Trembath, R. C., & Barker, J. N. (2012). Psoriasis and other complex trait dermatoses: from Loci to functional pathways. Journal of investigative dermatology, 132(3), 915-922. https://doi.org/10.1038/jid.2011.395
Chen, L., Deng, H., Cui, H., Fang, J., Zuo, Z., Deng, J., … & Zhao, L. (2018). Inflammatory responses and inflammation-associated diseases in organs. Oncotarget, 9(6), 7204. https://doi.org/10.18632/oncotarget.23208
Cho, S. K., Kim, D., Won, S., Lee, J., Choi, C. B., Choe, J. Y., Hong, S. J., Jun, J. B., Kim, T. H., Koh, E., Lee, H. S., Lee, J., Yoo, D. H., Yoon, B. Y., Bae, S. C., & Sung, Y. K. (2019). Factors associated with time to diagnosis from symptom onset in patients with early rheumatoid arthritis. The Korean journal of internal medicine, 34(4), 910–916. https://doi.org/10.3904/kjim.2017.113
Cukic, V., Lovre, V., Dragisic, D., & Ustamujic, A. (2012). Asthma and Chronic Obstructive Pulmonary Disease (COPD) – Differences and Similarities. Materia socio-medica, 24(2), 100–105. https://doi.org/10.5455/msm.2012.24.100-105
Das, S., Ghosh, S., De, A. K., & Bera, T. (2017). Oral delivery of ursolic acid-loaded nanostructured lipid carrier coated with chitosan oligosaccharides: Development, characterization, in vitro and in vivo assessment for the therapy of leishmaniasis. International journal of biological macromolecules, 102, 996–1008. https://doi.org/10.1016/j.ijbiomac.2017.04.098
Day, A. S., & Lemberg, D. A. (2020). Identification and diagnosis of Crohn disease and ulcerative colitis in children. Journal of paediatrics and child health, 56(11), 1731–1734. https://doi.org/10.1111/jpc.14925
Dianzani, C., Foglietta, F., Ferrara, B., Rosa, A. C., Muntoni, E., Gasco, P., … & Serpe, L. (2017). Solid lipid nanoparticles delivering anti-inflammatory drugs to treat inflammatory bowel disease: Effects in an in vivo model. World journal of gastroenterology, 23(23), 4200. https://doi.org/10.3748/wjg.v23.i23.4200
Doktorovova, S., Kovačević, A. B., Garcia, M. L., & Souto, E. B. (2016). Preclinical safety of solid lipid nanoparticles and nanostructured lipid carriers: Current evidence from in vitro and in vivo evaluation. European Journal of Pharmaceutics and Biopharmaceutics, 108, 235-252. https://doi.org/10.1016/j.ejpb.2016.08.001
Doppalapudi, S., Jain, A., Chopra, D. K., & Khan, W. (2017). Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis. European journal of pharmaceutical sciences: official journal of the European Federation for Pharmaceutical Sciences, 96, 515–529. https://doi.org/10.1016/j.ejps.2016.10.025
Ferrara, G., Petrillo, M. G., Giani, T., Marrani, E., Filippeschi, C., Oranges, T., Simonini, G., & Cimaz, R. (2019). Clinical Use and Molecular Action of Corticosteroids in the Pediatric Age. International journal of molecular sciences, 20(2), 444. https://doi.org/10.3390/ijms20020444
Garg, N. K., Tandel, N., Bhadada, S. K., & Tyagi, R. K. (2021). Nanostructured Lipid Carrier-Mediated Transdermal Delivery of Aceclofenac Hydrogel Present an Effective Therapeutic Approach for Inflammatory Diseases. Frontiers in pharmacology, 12, 713616. https://doi.org/10.3389/fphar.2021.713616
Garg, N. K., Tyagi, R. K., Singh, B., Sharma, G., Nirbhavane, P., Kushwah, V., … & Katare, O. P. (2016). Nanostructured lipid carrier mediates effective delivery of methotrexate to induce apoptosis of rheumatoid arthritis via NF-κB and FOXO1. International journal of pharmaceutics, 499(1-2), 301-320. https://doi.org/10.1016/j.ijpharm.2015.12.061
Ge, X., Wei, M., He, S., & Yuan, W. E. (2019).Advances of Non-Ionic Surfactant Vesicles (Niosomes) and Their Application in Drug Delivery. Pharmaceutics, 11(2), 55. https://doi.org/10.3390/pharmaceutics11020055
Ghasemiyeh, P., & Mohammadi-Samani, S. (2018). Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages. Research in pharmaceutical sciences, 13(4), 288–303. https://doi.org/10.4103/1735-5362.235156
Gordillo-Galeano, A., & Mora-Huertas, C. E. (2018). Solid lipid nanoparticles and nanostructured lipid carriers: A review emphasizing on particle structure and drug release. European Journal of Pharmaceutics and Biopharmaceutics, 133, 285-308. https://doi.org/10.1016/j.ejpb.2018.10.017
Guo, Q., Wang, Y., Xu, D., Nossent, J., Pavlos, N. J., & Xu, J. (2018). Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone research, 6, 15. https://doi.org/10.1038/s41413-018-0016-9
Honmane, S., Hajare, A., More, H., Osmani, R. A. M., & Salunkhe, S. (2019). Lung delivery of nanoliposomal salbutamol sulfate dry powder inhalation for facilitated asthma therapy. Journal of liposome research, 29(4), 332-342. https://doi.org/10.1080/08982104.2018.1531022
Huguet-Casquero, A., Xu, Y., Gainza, E., Pedraz, J. L., & Beloqui, A. (2020). Oral delivery of oleuropein-loaded lipid nanocarriers alleviates inflammation and oxidative stress in acute colitis. International journal of pharmaceutics, 586, 119515. https://doi.org/10.1016/j.ijpharm.2020.119515
Hussein, J., El-Bana, M. A., El-kHayat, Z., El-Naggar, M. E., Farrag, A. R., & Medhat, D. (2022). Eicosapentaenoic acid loaded silica nanoemulsion attenuates hepatic inflammation through the enhancement of cell membrane components. Biological procedures online, 24(1), 11. https://doi.org/10.1186/s12575-022-00173-z
Janakiraman, K., Krishnaswami, V., Rajendran, V., Natesan, S., & Kandasamy, R. (2018). Novel nano therapeutic materials for the effective treatment of rheumatoid arthritis-recent insights. Materials today. Communications, 17, 200–213. https://doi.org/10.1016/j.mtcomm.2018.09.011
John, R., Monpara, J., Swaminathan, S., & Kalhapure, R. (2024). Chemistry and Art of Developing Lipid Nanoparticles for Biologics Delivery: Focus on Development and Scale-Up. Pharmaceutics, 16(1), 131. https://doi.org/10.3390/pharmaceutics16010131
Kahnert, K., Jörres, R. A., Behr, J., & Welte, T. (2023). The Diagnosis and Treatment of COPD and Its Comorbidities. DeutschesArzteblatt international, 120(25), 434–444. https://doi.org/10.3238/arztebl.m2023.027
Kaur, N., Sharma, K., & Bedi, N. (2018). Topical Nanostructured Lipid Carrier Based Hydrogel of Mometasone Furoate for the Treatment of Psoriasis. Pharmaceutical nanotechnology, 6(2), 133–143. https://doi.org/10.2174/2211738506666180523112513
Kaur, S., Goyal, A., Rai, A., Sharma, A., Ugoeze, K.C. & Singh, I. (2023). Quercetin nanoformulations: recent advancements and therapeutic applications. Advances in Natural Sciences: Nanoscience and Nanotechnology, 14(3), p.033002. https://doi.org10.1088/2043-6262/acedaa
Kazi, K. M., Mandal, A. S., Biswas, N., Guha, A., Chatterjee, S., Behera, M., & Kuotsu, K. (2010).Niosome: A future of targeted drug delivery systems. Journal of advanced pharmaceutical technology & research, 1(4), 374–380. https://doi.org/10.4103/0110-5558.76435
Knight A. (2020). Managing the overlap of asthma and chronic obstructive pulmonary disease. Australian prescriber, 43(1), 7–11. https://doi.org/10.18773/austprescr.2020.002
Krishnan, Y., Mukundan, S., Akhil, S., Gupta, S., & Viswanad, V. (2018). Enhanced Lymphatic Uptake of Leflunomide Loaded Nanolipid Carrier via Chylomicron Formation for the Treatment of Rheumatoid Arthritis. Advanced pharmaceutical bulletin, 8(2), 257–265. https://doi.org/10.15171/apb.2018.030
Kumar Sarwa, K., Rudrapal, M., & Mazumder, B. (2015). Topical ethosomal capsaicin attenuates edema and nociception in arthritic rats. Drug delivery, 22(8), 1043–1052. https://doi.org/10.3109/10717544.2013.861041
Lei, F., Zeng, F., Yu, X., Deng, Y., Zhang, Z., Xu, M., … & Li, C. (2023). Oral hydrogel nanoemulsion co-delivery system treats inflammatory bowel disease via anti-inflammatory and promoting intestinal mucosa repair. Journal of Nanobiotechnology, 21(1), 275. https://doi.org/10.1186/s12951-023-02045-4
Leong, E. W. X., & Ge, R. (2022). Lipid Nanoparticles as Delivery Vehicles for Inhaled Therapeutics. Biomedicines, 10(9), 2179. https://doi.org/10.3390/biomedicines10092179
Li, N., Qin, Y., Dai, D., Wang, P., Shi, M., Gao, J., Yang, J., Xiao, W., Song, P., & Xu, R. (2022). Transdermal Delivery of Therapeutic Compounds With Nanotechnological Approaches in Psoriasis. Frontiers in bioengineering and biotechnology, 9, 804415. https://doi.org/10.3389/fbioe.2021.804415
Li, Y., Ji, Z., Wang, Y., Li, X., & Xie, Y. (2022). Breathing Exercises in the Treatment of COPD: An Overview of Systematic Reviews. International journal of chronic obstructive pulmonary disease, 17, 3075–3085. https://doi.org/10.2147/COPD.S385855
Liao, C. C., Yu, H. P., Yang, S. C., Alalaiwe, A., Dai, Y. S., Liu, F. C., & Fang, J. Y. (2021). Multifunctional lipid-based nanocarriers with antibacterial and anti-inflammatory activities for treating MRSA bacteremia in mice. Journal of nanobiotechnology, 19(1), 48.https://doi.org/10.1186/s12951-021-00789-5
Lin, Y. K., Huang, Z. R., Zhuo, R. Z., & Fang, J. Y. (2010). Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery. International journal of nanomedicine, 5, 117–128. https://doi.org/10.2147/ijn.s9155
Liu, H., Li, Y., Zhang, X., Shi, M., Li, D., & Wang, Y. (2022). Chitosan-Coated Solid Lipid Nano-Encapsulation Improves the Therapeutic Antiairway Inflammation Effect of Berberine against COPD in Cigarette Smoke-Exposed Rats. Canadian respiratory journal, 2022, 8509396. https://doi.org/10.1155/2022/8509396
Lv, C., Li, H., Cui, H., Bi, Q., & Wang, M. (2021). Solid lipid nanoparticle delivery of rhynchophylline enhanced the efficiency of allergic asthma treatment via the upregulation of suppressor of cytokine signaling 1 by repressing the p38 signaling pathway. Bioengineered, 12(1), 8635-8649. https://doi.org/10.1080/21655979.2021.1988364
Marinho, S., Illanes, M., Ávila-Román, J., Motilva, V., & Talero, E. (2021). Anti-inflammatory effects of rosmarinic acid-loaded nanovesicles in acute colitis through modulation of NLRP3 inflammasome. Biomolecules, 11(2), 162. https://doi.org/10.3390/biom11020162
Mishra, R. K., Ahmad, A., Kumar, A., Ali, A., Kanika, Jori, C., Tabrez, S., Zughaibi, T. A., Almashjary, M. N., Raza, S. S., & Khan, R. (2023). Cortisone-loaded stearoyl ascorbic acid based nanostructured lipid carriers alleviate inflammatory changes in DSS-induced colitis. Biomaterials advances, 148, 213383. https://doi.org/10.1016/j.bioadv.2023.213383
Mishra, R. K., Ahmad, A., Kumar, A., Vyawahare, A., Raza, S. S., & Khan, R. (2020). Lipid-based nanocarrier-mediated targeted delivery of celecoxib attenuate severity of ulcerative colitis. Materials science & engineering. C, Materials for biological applications, 116, 111103. https://doi.org/10.1016/j.msec.2020.111103
Müller, R. H., Shegokar, R., & Keck, C. M. (2011). 20 years of lipid nanoparticles (SLN and NLC): present state of development and industrial applications. Current drug discovery technologies, 8(3), 207–227. https://doi.org/10.2174/157016311796799062
Nsairat, H., Khater, D., Sayed, U., Odeh, F., Al Bawab, A., & Alshaer, W. (2022). Liposomes: structure, composition, types, and clinical applications. Heliyon, 8(5), e09394. https://doi.org/10.1016/j.heliyon.2022.e09394
Nyandoro, V. O., Omolo, C. A., Ismail, E. A., Yong, L., & Govender, T. (2023). Inflammation-responsive drug delivery nanosystems for treatment of bacterial-induced sepsis. International journal of pharmaceutics, 644, 123346. https://doi.org/10.1016/j.ijpharm.2023.123346
Olival, A., Vieira, S. F., Gonçalves, V. M. F., Cunha, C., Tiritan, M. E., Carvalho, A., Reis, R. L., Ferreira, H., & Neves, N. M. (2022). Erythrocyte-derived liposomes for the treatment of inflammatory diseases. Journal of drug targeting, 30(8), 873–883. https://doi.org/10.1080/1061186X.2022.2066107
Pal, R. R., Rajpal, V., Singh, N., Singh, S., Mishra, N., Singh, P., Maurya, P., Alka, &Saraf, S. A. (2023). Downregulation of pro-inflammatory markers IL-6 and TNF-α in rheumatoid arthritis using nano-lipidic carriers of a quinone-based phenolic: an in vitro and in vivo study. Drug delivery and translational research, 13(2), 627–641. https://doi.org/10.1007/s13346-022-01221-7
Paradkar, M., & Vaghela, S. (2018). Thiocolchicoside niosomal gel formulation for the pain management of rheumatoid arthritis through topical drug delivery. Drug Delivery Letters, 8(2), 159-168. https://doi.org/10.2174/2210303108666180216151234
Pham, C. T. (2011). Nanotherapeutic approaches for the treatment of rheumatoid arthritis. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 3(6), 607-619. https://doi.org/10.1002/wnan.157
Plaza-Oliver, M., Beloqui, A., Santander-Ortega, M. J., Castro-Vázquez, L., Rodríguez-Robledo, V., Arroyo-Jiménez, M. M., Préat, V., & Lozano, M. V. (2020). Ascorbyl-dipalmitate-stabilised nanoemulsions as a potential localised treatment of inflammatory bowel diseases. International journal of pharmaceutics, 586, 119533. https://doi.org/10.1016/j.ijpharm.2020.119533
Plaza-Oliver, M., Santander-Ortega, M. J., & Lozano, M. V. (2021). Current approaches in lipid-based nanocarriers for oral drug delivery. Drug delivery and translational research, 11(2), 471–497. https://doi.org/10.1007/s13346-021-00908-7
Preeti, Sambhakar, S., Malik, R., Bhatia, S., Al Harrasi, A., Rani, C., Saharan, R., Kumar, S., Geeta, & Sehrawat, R. (2023). Nanoemulsion: An Emerging Novel Technology for Improving the Bioavailability of Drugs. Scientifica, 2023, 6640103. https://doi.org/10.1155/2023/6640103
Raj, S., & Unsworth, L. D. (2023). Targeting active sites of inflammation using inherent properties of tissue-resident mast cells. Acta biomaterialia, 159, 21–37. https://doi.org/10.1016/j.actbio.2023.01.024
Rajizadeh, M. A., Najafipour, H., SamarehFekr, M., Rostamzadeh, F., Jafari, E., Bejeshk, M. A., & Masoumi-Ardakani, Y. (2019). Anti-Inflammatory and Anti-Oxidative Effects of Myrtenol in the Rats with Allergic Asthma. Iranian journal of pharmaceutical research: IJPR, 18(3), 1488–1498. https://doi.org/10.22037/ijpr.2019.1100749
Rajizadeh, M. A., Nematollahi, M. H., Jafari, E., Bejeshk, M. A., Mehrabani, M., Razeghinia, M. S., & Najafipour, H. (2023). Niosome nanocarrier enhances the ameliorating effects of myrtenol in the lungs of rats with experimental asthma. OpenNano, 11, 100129. https://doi.org/10.1016/j.onano.2023.100129
Rapalli, V. K., Kaul, V., Waghule, T., Gorantla, S., Sharma, S., Roy, A., Dubey, S. K., & Singhvi, G. (2020). Curcumin loaded nanostructured lipid carriers for enhanced skin retained topical delivery: optimization, scale-up, in-vitro characterization and assessment of ex-vivo skin deposition. European journal of pharmaceutical sciences: official journal of the European Federation for Pharmaceutical Sciences, 152, 105438. https://doi.org/10.1016/j.ejps.2020.105438
Rathi, R., Kaur, S., Chopra, H., Kaur, M., Kumar, S. & Singh, I. (2024). Advancements in microsponges for the management of vaginal and colorectal diseases: A comprehensive review. Applied Chemical Engineering, 2334-2334. 10.59429/ace.v7i2.2334
Rinaldi, F., Del Favero, E., Rondelli, V., Pieretti, S., Bogni, A., Ponti, J., Rossi, F., Di Marzio, L., Paolino, D., Marianecci, C., & Carafa, M. (2017).pH-sensitive niosomes: Effects on cytotoxicity and on inflammation and pain in murine models. Journal of enzyme inhibition and medicinal chemistry, 32(1), 538–546. https://doi.org/10.1080/14756366.2016.1268607
Rizvi, S. A. A., & Saleh, A. M. (2018).Applications of nanoparticle systems in drug delivery technology. Saudi pharmaceutical journal: SPJ : the official publication of the Saudi Pharmaceutical Society, 26(1), 64–70. https://doi.org/10.1016/j.jsps.2017.10.012
Roe, K. (2021). An inflammation classification system using cytokine parameters. Scandinavian journal of immunology, 93(2), e12970. https://doi.org/10.1111/sji.12970
Rossi, J. F., Lu, Z. Y., Massart, C., & Levon, K. (2021). Dynamic Immune/Inflammation Precision Medicine: The Good and the Bad Inflammation in Infection and Cancer. Frontiers in immunology, 12, 595722. https://doi.org/10.3389/fimmu.2021.595722
Sathe, P., Saka, R., Kommineni, N., Raza, K., & Khan, W. (2019). Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model. Drug development and industrial pharmacy, 45(5), 826–838. https://doi.org/10.1080/03639045.2019.1576722
Sercombe, L., Veerati, T., Moheimani, F., Wu, S. Y., Sood, A. K., & Hua, S. (2015). Advances and Challenges of Liposome Assisted Drug Delivery. Frontiers in pharmacology, 6, 286. https://doi.org/10.3389/fphar.2015.00286
Sharma, M., Rathi, R., Kaur, S., Singh, I., Abd Kadir, E., Chahardehi, A. M., & Lim, V. (2023). Antiinflammatory activity of herbal bioactive-based formulations for topical administration. In Recent Developments in Anti-Inflammatory Therapy, 245-277. Academic Press. https://doi.org/10.1016/B978-0-323-99988-5.00015-2
Shinde, C., Venkatesh, M. P., Pramod Kumar, T., & Pai, D. R. (2021). Nanostructured lipid carrier-based smart gel: a delivery platform for intra-articular therapeutics. Autoimmunity, 54(1), 35–44. https://doi.org/10.1080/08916934.2020.1846184
Souto, E. B., Cano, A., Martins-Gomes, C., Coutinho, T. E., Zielińska, A., & Silva, A. M. (2022). Microemulsions and Nanoemulsions in Skin Drug Delivery. Bioengineering (Basel, Switzerland), 9(4), 158. https://doi.org/10.3390/bioengineering9040158
Subramaniam, S., Elz, A., Wignall, A., Kamath, S., Ariaee, A., Hunter, A., Newblack, T., Wardill, H. R., Prestidge, C. A., & Joyce, P. (2023). Self-emulsifying drug delivery systems (SEDDS) disrupt the gut microbiota and trigger an intestinal inflammatory response in rats. International journal of pharmaceutics, 648, 123614. https://doi.org/10.1016/j.ijpharm.2023.123614
Tetyczka, C., Hartl, S., Jeitler, R., Absenger-Novak, M., Meindl, C., Fröhlich, E., Riedl, S., Zweytick, D., & Roblegg, E. (2021).Cytokine-Mediated Inflammation in the Oral Cavity and Its Effect on Lipid Nanocarriers. Nanomaterials (Basel, Switzerland), 11(5), 1330. https://doi.org/10.3390/nano11051330
Umerska, A., Mouzouvi, C. R., Bigot, A., & Saulnier, P. (2015).Formulation and nebulization of fluticasone propionate-loaded lipid nanocarriers. International journal of pharmaceutics, 493(1-2), 224–232. https://doi.org/10.1016/j.ijpharm.2015.07.008
Viegas, J. S. R., Praça, F. G., Caron, A. L., Suzuki, I., Silvestrini, A. V. P., Medina, W. S. G., Del Ciampo, J. O., Kravicz, M., & Bentley, M. V. L. B. (2020). Nanostructured lipid carrier co-delivering tacrolimus and TNF-α siRNA as an innovate approach to psoriasis. Drug delivery and translational research, 10(3), 646–660. https://doi.org/10.1007/s13346-020-00723-6
Walunj, M., Doppalapudi, S., Bulbake, U., & Khan, W. (2020). Preparation, characterization, and in vivo evaluation of cyclosporine cationic liposomes for the treatment of psoriasis. Journal of liposome research, 30(1), 68–79. https://doi.org/10.1080/08982104.2019.1593449
Wen, J., Li, H., Dai, H., Hua, S., Long, X., Li, H., … & Xu, C. (2023). Intra-articular nanoparticles based therapies for osteoarthritis and rheumatoid arthritis management. Materials Today Bio, 19, 100597. https://doi.org/10.1016/j.mtbio.2023.100597
Witika, B. A., Bassey, K. E., Demana, P. H., Siwe-Noundou, X., & Poka, M. S. (2022). Current Advances in Specialised Niosomal Drug Delivery: Manufacture, Characterization and Drug Delivery Applications. International journal of molecular sciences, 23(17), 9668. https://doi.org/10.3390/ijms23179668
Yang, C., & Merlin, D. (2019). Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives. International journal of nanomedicine, 14, 8875–8889. https://doi.org/10.2147/IJN.S210315
Yasmin, F., Najeeb, H., Shaikh, S., Hasanain, M., Naeem, U., Moeed, A., Koritala, T., Hasan, S., & Surani, S. (2022). Novel drug delivery systems for inflammatory bowel disease. World journal of gastroenterology, 28(18), 1922–1933. https://doi.org/10.3748/wjg.v28.i18.1922
Zhao, Y., Yang, Y., Zhang, J., Wang, R., Cheng, B., Kalambhe, D., … & Huang, Y. (2020). Lactoferrin-mediated macrophage targeting delivery and patchouli alcohol-based therapeutic strategy for inflammatory bowel diseases. Acta Pharmaceutica Sinica B, 10(10), 1966-1976. https://doi.org/10.1016/j.apsb.2020.07.019
Zuo, X., Gu, Y., Guo, X., Zheng, W., Zheng, H., An, Y., … & Wang, F. (2024). Preparation of Budesonide-Loaded Liposomal Nanoparticles for Pulmonary Delivery and Their Therapeutic Effect in OVA-Induced Asthma in Mice. International journal of nanomedicine, 673-688. https://doi.org/10.2147/IJN.S441345

How to Cite

Kumar Anand , Sayak Khawas , Apurva Singh , Rashmi Kumari and Neelima Sharma. Recent Advances in Lipid Nano-Carrier Systems for the Management of Inflammatory Diseases: A Comprehensive Review. J. Pharm. Technol. Res. Manag.. 2023, 11, 77-92

Recent Advances in Lipid Nano-Carrier Systems for the Management of Inflammatory Diseases: A Comprehensive Review

Current Issue

Periodicity	Biannually
Issue-1	May
Issue-2	November
ISSN Print	2321-2217
ISSN Online	2321-2225
RNI No.	CHAENG/2013/50088

OA Policy

Publisher's policy of the journal at Sherpa UK for the submitted, accepted, and published articles. Click OAPolicy

Plan-S Compliance

To check compliance, one has to use the Journal Check Tool (JCT). This tool provided by cOAlition S (European funders) for the researchers (fundee) to check the compliance with the journal.

Recommend journal to your library

You can recommend the journal being a researcher or faculty member to your library. We will post a copy of the Journal to your library on your behalf at free of cost.
Click here: Recommend Journal

Preprint Arxiv Submission

The authors are encouraged to submit the author’s copy (preprint) to appropriate preprint archives e.g. https://arxiv.org and/or on https://indiarxiv.org or institutional repositories (e.g., D Space) before paper acceptance by the editor of Journal. After publications of the paper author(s) should mention the citation information, title and abstract along with DOI number of the publication carefully on the required page of the depository(ies).

Contact: Phone: +91-172-2741000, +91-172-4691800

Email : editor.jptrm@chitkara.edu.in;

Abstract and Indexing

Information

This work is licensed under a Creative Commons Attribution 4.0 International License.

Articles in Journal of Pharmaceutical Technology, Research and Management (J. Pharm. Tech. Res. Management) by Chitkara University Publications are Open Access articles that are published with licensed under a Creative Commons Attribution- CC-BY 4.0 International License. Based on a work at https://jptrm.chitkara.edu.in/. This license permits one to use, remix, tweak and reproduction in any medium, even commercially provided one give credit for the original creation.

View Legal Code of the above-mentioned license, https://creativecommons.org/licenses/by/4.0/legalcode

View Licence Deed here https://creativecommons.org/licenses/by/4.0/